title: Management of human immunodeficiency virus in primary care.
abstract: This article presents an overview of current human immunodeficiency (HIV) management for primary care practitioners. Discussion is focused on appropriate screening, antiretroviral treatment, opportunistic infection prophylaxis, laboratory testing and prevention. Improved screening can identify the 20-25% of persons living with HIV in the United States who remain undiagnosed. Expansion of treatment recommendations to include all HIV-infected persons and expanded opportunities for prophylaxis will likely significantly increase the number of persons who receive antiretroviral treatment. Understanding of opportunistic infection prophylaxis, proper vaccination, and comorbid risk factor modification can improve life expectancy for many patients living with chronic stable HIV infection.
authors: Penn State Hershey Department of Family and Community Medicine, Penn State Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA 17033, USA. jsell@hmc.psu.edu
authors: Jarrett K
authors: JK
authors: Sell
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000517:prevention & control*; D000890:Anti-Infective Agents / Q000627:therapeutic use; D044966:Anti-Retroviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D019468:Disease Management; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000175:diagnosis* / Q000188:drug therapy* / Q000503:physiopathology; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008017:Life Expectancy; D008403:Mass Screening; D011320:Primary Health Care; D012307:Risk Factors; D013997:Time Factors; D014481:United States / Q000453:epidemiology
chemical_list: D000890:Anti-Infective Agents; D044966:Anti-Retroviral Agents
keywords: Antiretroviral; Human immunodeficiency virus; Opportunistic infections; Pre-exposure prophylaxis